Search Results

Pergolide: voluntary withdrawal of products.

Subjects: *ANTIPARKINSONIAN agents; *DRUG side effects; *HEART valvesUNITED StatesUNITED States. Food & Drug Administration

• Source: WHO Drug Information. 2007, Vol. 21 Issue 2, p112-113. 2p.

Record details

LEVODOPA.

Subjects: *DOPA; *ANTIPARKINSONIAN agents; *PHARMACOPOEIASINTERNATIONAL Pharmacopoeia, The (Book)

• Source: International Pharmacopoeia: Fourth Edition. 2006, Vol. 1, p548-551. 4p.

Record details

CARBIDOPA.

Subjects: *ANTIPARKINSONIAN agents; *DRUG therapy for Parkinson's disease; *PHARMACOPOEIASINTERNATIONAL Pharmacopoeia, The (Book)

• Source: International Pharmacopoeia: Fourth Edition. 2006, Vol. 1, p209-211. 3p.

Record details

BIPERIDEN HYDROCHLORIDE.

Subjects: *ZINC enzymes; *ANTIPARKINSONIAN agents; *CENTRAL nervous system depressantsINTERNATIONAL Pharmacopoeia, The (Book)

• Source: International Pharmacopoeia: Fourth Edition. 2006, Vol. 1, p170-171. 2p.

Record details

BIPERIDEN.

Subjects: *ANTIPARKINSONIAN agents; *CENTRAL nervous system depressants; *DRUGSINTERNATIONAL Pharmacopoeia, The (Book)

• Source: International Pharmacopoeia: Fourth Edition. 2006, Vol. 1, p171-173. 3p.

Record details

Safety and Efficacy Issues.

Subjects: HYPERTONIC saline solutions; LYME disease diagnosis; ACETIC acid

• Source: WHO Drug Information. 2012, Vol. 26 Issue 4, p371-382. 12p.

Record details

Levodopa/carbidopa/entacapone: withdrawal of application for extension of indication

• Source: WHO Drug Information. Spring, 2009, Vol. 23 Issue 2, p120, 2 p.

Record details

Domperidone: heart rate and rhythm disorders.

• Source: WHO Drug Information. 2007, Vol. 21 Issue 1, p11-12. 2p.

Record details

Levofloxacin: dysglycemia and liver disorder.

• Source: WHO Drug Information. 2007, Vol. 21 Issue 1, p10-11. 2p.

Record details

Regulatory Matters

• Source: WHO Drug Information. Spring, 1999, Vol. 13 Issue 2, p91

Record details